longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

JAFRON: The extracorporeal circulation blood pathway of the blood purification device has obtained EU MDR certification

Zhitong
Jun 18, 2025 at 10:20 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

According to the Zhitong Finance APP, JAFRON announced that the company recently received a notification from the EU announcement agency, stating that the company's blood purification device's extracorporeal circulation blood path has obtained the EU MDR certification issued in accordance with the EU Medical Devices Regulation (EU) 2017/745 (referred to as "MDR"), allowing it to be sold in EU countries and other countries that recognize EU CE certification

According to the Zhitong Finance APP, JAFRON (300529.SZ) announced that the company recently received a notification from the EU announcement agency, stating that the company's blood purification device's extracorporeal circulation blood pathway has obtained the EU MDR certification issued in accordance with the EU Medical Devices Regulation (EU) 2017/745 (referred to as "MDR"), allowing it to be sold in EU countries and other countries that recognize EU CE certification

Login to unlock483characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

JAFRON

JAFRON

300529.SZ

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--

LongbridgeAI